When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

8.11.2024

Stem cell therapy for degenerative joint diseases

In an interview with Ö24, Univ.-Prof. Dr. Michael Zimpfer, MBA, orthopedist and head of the pain management center in Vienna, provides interesting insights into the use of stem cell therapy for degenerative joint diseases. As an expert in minimally invasive and conservative pain management, Prof. Dr. Zimpfer explains the latest developments in regenerative medicine and describes the positive influence of stem cell therapy on the treatment of osteoarthritis.

Dr. Michael Zimpfer im Interview bei "Good Morning Austria" auf Ö24, diskutiert ein Thema am Studiotisch mit leuchtendem Hintergrund und Werbehinweis zu Stammzelltherapie: www.zmed.at

An interview with Univ.-Prof. Dr. Michael Zimpfer

Your own joint, when it works without pain, is still the best. We are committed to this“, says Prof. Dr. Zimpfer, highlighting how stem cells can help maintain joint function in the long term and thus prevent joint replacement.

I don't have a single patient who has needed a joint replacement after stem cell therapy“, says Prof. Dr. Zimpfer.

Stem cell therapy for tissue regeneration and pain relief

By specifically activating biological mechanisms, the stem cell therapy tissue regeneration and relieves pain. This innovative approach offers a promising alternative to classic joint replacement and has proven to be extremely successful in clinical practice.

Extraction of stem cells with Miracell®

Miracell® - stem cell isolation system enables an innovative method for obtaining high-quality autologous stem cells from whole blood or bone marrow. Thanks to the patented Miracell® technology The cell survival rate is increased as cell damage is prevented through precise density calculation and reduced intercellular friction. In order to isolate the various cell structures from bone marrow or blood, special isolating valves have been developed, which ensure exact separation and concentration of the cells.

In addition, innovative LED technology supports cells during the centrifugation process: Different light wavelengths — from blue to red — stimulate the cells in a targeted manner and promote various processes such as immune response, blood circulation and cell growth.

For more information about Miracell®, visit our Product page.

Für weitere Informationen kontaktieren Sie bitte:

More posts

Sponsoring

Lotteries Sporthilfe Gala 2024: A Celebration of Austrian Sports Talent

Outstanding local athletes were honored at the 28th LOTTERIES Sports Aid Gala in the Wiener Stadthalle.
Sponsoring

Haemo Pharma & WINBACK: Live at the Erste Bank Open 2024!

From 19-27. 10, the best tennis players will fight at the Erste Bank Open and we are proud to be an official sponsor.
Product Update

Matrix Augmented Bone Marrow Stimulation (mBMS) with Hyalofast®

JATROS special report: Dr. Obewegeser about the MBMS method with Hyalofast®

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.